Opal Wealth Advisors’s LeMaitre Vascular LMAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-217
Closed -$23.7K 421
2026
Q1
$23.7K Buy
+217
New +$20.7K 0.01% 562
2025
Q3
Sell
-321
Closed -$26.7K 388
2025
Q2
$26.7K Buy
321
+17
+6% +$1.42K 0.01% 498
2025
Q1
$25.5K Buy
+304
New +$28.3K 0.01% 479
2024
Q3
Sell
-162
Closed -$13.3K 755
2024
Q2
$13.3K Buy
+162
New +$11.9K ﹤0.01% 602

Other funds holding LMAT

Opal Wealth Advisors's LMAT Position: Q2 2026 in Review

Opal Wealth Advisors sold out of LeMaitre Vascular (LMAT) in Q2 2026, closing a stake of 217 shares — an estimated $23.7K sold.

Opal Wealth Advisors first reported a position in LMAT in Q2 2024 and held it in 4 quarters. The position peaked at $26.7K in Q2 2025. 326 funds tracked by Wall St. Rank hold LMAT as of Q2 2026.

  • Opal Wealth Advisors reported no remaining LeMaitre Vascular position as of Q2 2026 after selling out during the quarter.
  • Opal Wealth Advisors sold 217 LeMaitre Vascular shares in Q2 2026, an estimated $23.7K.
  • Opal Wealth Advisors first reported a position in LeMaitre Vascular in Q2 2024 and held it in 4 quarters.
  • Opal Wealth Advisors's LeMaitre Vascular position peaked at $26.7K in Q2 2025.
  • 326 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q2 2026.

Based on Opal Wealth Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.